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Abstract 
Accumulated evidence indicates that neuroinflammation induces insulin resistance in the brain. 
Moreover, both processes are intimately linked to neurodegenerative disorders, including Alzheimer’s 
disease. Potential mechanisms underlying insulin resistance include serine phosphorylation of the insulin 
receptor substrate (IRS) or insulin receptor (IR) misallocation. However, only a few studies have focused 
on IRS expression in the brain and its modulation in neuroinflammatory processes.  
This study used the high-fat diet (HFD) model of neuroinflammation to study the alterations of IR, an 
insulin-like growth factor receptor (IGF1R) and IRS expressions in the hippocampus. We observed that 
HFD effectively reduced mRNA and protein IRS2 expression. In contrast, a HFD induced the 
upregulation of the IRS1 mRNA levels, but did not alter an IR and IGF1R expression. As expected, we 
observed that a HFD increased hippocampal tumour necrosis factor alpha (TNFα) and amyloid precursor 
protein (APP) levels while reducing Brain derived neurotrophic factor (BDNF) expression and 
neurogenesis. Interestingly, we found that TNFα correlated positively with IRS1 and negatively with 
IRS2, whereas APP levels correlated positively only with IRS1 but not IRS2. These results indicate that 
IRS1 and IRS2 hippocampal expression can be affected differently by HFD-induced neuroinflammation. 
In addition, we aimed to establish whether abscisic acid (ABA) can rescue hippocampal IRS1 and IRS2 
expression, as we had previously shown that ABA supplementation prevents memory impairments and 
improves neuroinflammation induced by a HFD. In this study, ABA restored HFD-induced hippocampal 
alterations, including IRS1 and IRS2 expression, TNFα, APP and BDNF levels and neurogenesis. In 
conclusion, this study highlights different regulations of hippocampal IRS1 and IRS2 expression using an 
HFD, indicating the important differences of these scaffolding proteins, and strongly supports ABA 
therapeutic effects. 
 
 
Introduction 
Adult neurogenesis is a sensitive process that is very susceptible to different toxic insults, such as the 
presence of beta amyloid plaques (characteristic in Alzheimer’s disease) [1], insulin resistance [2] or 
inflammation [3]. Impairment of neurogenesis is associated with alterations of hippocampal-dependent 
functions, including spatial awareness, long-term memory, emotionality and mood [4, 5]. 
For more than 20 years, neuroinflammation has been considered to underlie the onset of 
neurodegenerative disorders [6], including Alzheimer’s disease [7–10]. Importantly, neuroinflammatory 
processes resulting from obesity and stress can induce insulin resistance [11]. These processes cause a 
considerable increase of reactive microglia, which secrete a variety of cytokines (e.g. TNFα), which 
activate specific intracellular cascades, including IKKβ and JNK [12]. Aside from this, a large body of 
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evidence has accumulated correlating insulin resistance induced by chronic inflammatory processes and 
the development of the disease [13]. In contrast, numerous preclinical and clinical studies have shown 
how  insulin sensitization improved cognitive damage, cytokine levels and mitochondrial function after a 
fat enriched-diet period [14, 15].  
Interestingly, insulin/IGF1 signalling has been shown to protect against these toxic insults and improves 
neurogenesis [16]. In line with this, physical exercise improves insulin sensitivity and increases 
hippocampal neurogenesis [17, 18]. The mechanisms of the exercise-induced improvement of 
neurogenesis may be a result of several factors, importantly the augmented blood flow to the brain [19] 
with the consequent affluence of growth factors, in particular IGF1 [20]. Highlighting the importance of 
IGF1, pilocarpine-induced epilepsy has been shown to increase the IGF1 expression via CREB 
stimulation in the SGZ-surrounding microglia, improving neurogenesis [21]. Another important factor in 
neurogenesis is the brain derived neuronal factor (BDNF) [22]. In fact, there is evidence that hippocampal 
BDNF expression is also augmented by exercise [23]. Furthermore, a crosstalk between BDNF and IGF1 
has been reported to play an important role in exercise-induced neurogenesis [24] 
Insulin and IGF1 signalling cascades are very similar: both peptides exert their actions through tyrosine 
kinase receptors via the subsequent activation of the IRSs [25–27]. Of the four known receptor substrates 
isoforms, the IRS1 and IRS2 isoforms are highly expressed in brain [28, 29]. Insulin and IGF1 receptors 
are expressed in dentate gyrus in rat and mouse brains [30–33], but the specific expression of the IRS in 
these areas is largely unknown. Neuroinflammation may induce insulin resistance through IRS 
inactivation by specific serine phosphorylation. In humans, IRS1 P-Ser 307 may determine insulin 
resistance in type 2 diabetes [34, 35]. One of the consequences of P-Ser in IRS1 is to increase the 
degradation of the protein using ubiquitination [36]. However, this process does not appear to occur for 
IRS2 degradation [37], which suggests differential regulation of both proteins, at least in certain cell 
types.  
In addition to exercise, other factors, such as phytohormones have been proposed as neuroprotectors, 
precisely due to their insulin sensitizer activity and anti-inflammatory properties [38]. For instance, ABA 
a PPARPγ agonist [39] can improve glucose tolerance in obesity models, reduce neuroinflammation and 
restore HFD-induced neurological alterations  [40–42]. The mechanism underling ABA action involves 
the activation of Lanthionine synthetase C-like 2 (LANCL2) [43, 44].  
In this study, we evaluate the effects of HFD-induced neuroinflammation and ABA treatment in the 
expression levels of several members of the insulin/IGF1 pathway, along with inflammation markers, in 
the hippocampus. One of the well-known effects of HFD exposure is the reduction of adult hippocampal 
neurogenesis [43]; therefore, we evaluated whether ABA treatment could rescue the HFD-induced 
reduction in hippocampal neurogenesis via its anti-inflammatory and insulin sensitizing properties. 
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Materials and methods 
Animals and diet 
Eight-week-old male Wistar rats (Janvier Labs, Saint-Berthevin, France) were kept at the animal facility 
of the University Jaume I. The procedures followed directive 86/609/EEC of the European Community on 
the protection of animals used for experimental and other scientific purposes. The experiments were 
approved by the Ethics Committee of the University Jaume I (approval number 2014/VSC/PEA00209). 
The animals were maintained on a 12 h:12 h light–dark cycle and housed in pairs to reduce stress due to 
social isolation. Rats were divided randomly into four experimental groups: SD, control animals fed the 
standard rodent diet (Ssniff, Soest, Germany); SD-ABA, animals fed standard diet supplemented with 
ABA (Fernandez-Rapado, Spain) in their drinking water (20 mg/L); HFD, animals fed an HFD (5736 
kcal/kg, Ssniff) and HFD-ABA, animals fed an HFD and that had ABA in their drinking water (20 mg/L). 
We have used ABA concentration as described [40]. The four groups were fed ad libitum for 12 weeks. 
Immunoblotting 
Rats were lightly anesthetized (Dolethal, 200 mg/Kg Vetoquinol S.A., Madrid, Spain) and then killed by 
decapitation. Brains were rapidly removed and frozen in cold isopentane (Sigma-Aldrich, St Louis, MO, 
USA). Hippocampi were dissected at ˗15 °C (using a cryostat) to preserve the protein phosphorylation. 
Tissue was lysed in a RIPA buffer containing protease and phosphatase inhibitors (SERVA 
Electrophoresis, Heidelberg, Germany). Mechanical tissue lysis was achieved using a sonicator (Hielsher 
Ultrasound Technology, Teltow, Germany). Thirty (30) µg of the total protein were subjected to SDS-
PAGE, transferred to Immobilon-P membranes (MERCK Millipore, Darmstadt Germany), which were 
blocked for non-specific binding and incubated with primary antibodies: anti-phospho IKKαβ (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA; 1:500); anti-phospho TAU (Abcam, Cambridge, UK; 1:1000); 
anti-SOD (Abcam, Cambridge, UK; 1:5000); anti-IRS1 (EMD Millipore, Temecula, CA, USA; 1:500); 
anti-IRS2 (Cell Signaling, Danvers, MA, USA 1:1000) and anti-β-Actin (Sigma-Aldrich, St Louis, MO, 
USA; 1:2000) overnight at 4 °C. After several washes with a washing buffer containing 0.3 % Triton X-
100, the membranes were incubated for 1 h at room temperature with peroxidase-conjugated secondary 
antibodies (anti-rabbit and anti-mouse, Jackson Immunoresearch, Suffolk, UK). Staining was developed 
using ECL (BioRad, Hercules CA, USA), and digital images were captured with a charge-coupled device 
imager (IMAGEQUANT LAS 4000, GE Healthcare Little Chalfont, UK). Immunoreactive bands were 
quantified with Image J blots toolkit software (National Institutes of Health, Baltimore, MD, USA), 
which was normalized to the β-Actin signal in each sample. Data were expressed as a percentage of the 
control (standard diet) normalized signal as the mean plus and minus the standard error of mean (SEM).  
Immunohistochemistry  
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Rats were anesthetized with pentobarbital (120 mg/kg Eutanax, Fatro, Barcelona, Spain) and 
transcardially perfused with saline (0.9 %), followed by a 4 % paraformaldehyde (PFA) fixative in 0.1 M 
phosphate buffer, pH 7.4. After perfusion, the brains were removed and post-fixed overnight at 4 °C in 
PFA, followed by 48 h in a 30 % sucrose solution for cryoprotection. Sliding Microtome Leica SM2010R 
(Leica Microsystems, Heidelberg, Germany) was used to obtain 40-µm thick coronal frozen sections. The 
brains were cut in rostrocaudal direction; six series of slices were collected from each brain and stored at 
˗20 °C. Sections were rinsed twice in 0.05 M Tris-buffered saline (TBS), pH 8.0, containing 0.2 % Triton 
X-100 at room temperature. Slices were incubated in blocking solution (containing 2 % donkey serum 
and 4 % serum albumin bovine for 1 h); anti-Doublecortin (DCX) (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA; 1:1000) was used. After several washes, the slides were incubated with the biotinylated 
secondary antibody (Jackson 1: 200) in TBS with 0.2 % Triton X-100. Then sections were rinsed 3x for 
10 mins and transferred to a 1:50 avidin–biotin–horseradish peroxidase complex solution for 90 mins 
(VECTASTAIN® Elite® ABC-HRP Kit; Peroxidase, Standard, USA). Then, sections were rinsed 2x for 
10 mins in TBS and 2x for 10 mins in 0.05 M 7.6 Ph Tris Buffer (TB). Colour reaction was achieved by 
incubation with DAB (Sigma-Aldrich, St Louis, MO, USA) and 2 µl of H2O2 in TB for 15-20 minutes. 
The reaction was stopped by several rinses in phosphate buffered saline solution. Finally, the slices were 
mounted on gelatinized slides and air dried overnight. Then, sections were rehydrated, alcohol 
dehydrated, xylene cleared and cover-slipped with a DPX mounting medium. 
Image Analysis 
Images were taken by a Nikon optical microscope (Nikon, Tokyo, Japan) attached to a Leica camera 
(Leica Microsystems), which was connected to the Leica software (Leica Microsystems), to acquire the 
images. To quantify the DCX positive neurons, six images were taken for each anatomical subdivision of 
the hippocampus in the four treatments (HFD, HFD-ABA, SD and SD-ABA). The DCX positive neurons 
were counted with Image J (National Institute of Health, Baltimore, MD, USA) at levels rostral (Bregma 
˗3.72mm) and caudal (Bregma ˗6.00mm) levels (Paxinos and Watson, 2013[45]). Data were expressed as 
the mean and the SEM of the DCX positive neurons (n = 6). The researcher performing the quantification 
of DCX positive neurons was blind to the experimental condition. 
RNA extraction and real-time quantitative polymerase chain reaction (RT-qPCR) 
Total RNA was extracted from the rat hippocampus (n = 5-11) and homogenized in 500 µL of lysis buffer 
according to the Norgen Fatty Tissue RNA Purification Kit (Norgen biotek corp, product #36200, ON, 
Canada). Genomic DNA was removed using a spin-column process during the RNA extraction. In 
addition, DNAse I treatment (Thermo-Fisher Scientific, Waltham, Massachusetts, USA) was performed 
to ensure the complete removal of genomic DNA. RNA samples were eluted in 50 µL of nuclease-free 
water and reverse transcribed to cDNA using a PrimeScript™ RT reagent kit (Takara, Shiga, Japan) 
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following the manufacturer’s instructions. Primers were designed using the Primer3 software tool 
(http://primer3.ut.ee/) (Table 1). RT-qPCR reactions were carried out using SYBR PREMIX Ex Taq (Tli 
RNase H Plus) (TAKARA Bio Inc., Shiga, Japan) in an Applied Biosystems StepOne Plus™ Real-Time 
PCR System (Foster City, California, USA). At the end of each PCR reaction, a melting curve stage was 
performed to confirm that only one PCR product was amplified in these reactions. The relative gene 
expression to SD was calculated by using the 2-ΔΔCt method for each reaction and by using the 
housekeeping gene GAPDH as internal control. 
 
Statistics 
Data were expressed as mean ± SEM and subjected to a Kolmogorov-Smirnov normality test, and only 
when the test was positive for normality (alpha= 0.05) were the data analysed using a parametric one-way 
analysis of variance (ANOVA) followed by a post-hoc Newman-Keuls test. To evaluate the associations 
between variables, we used a two-tailed Pearson correlation test. The correlation coefficient r values (± 
0.1 to ± 0.3) reveal a weak association, are a (± 0.3 to ± 0.5) medium and are higher than ± 0.5 strong 
correlation [46–48]. Positive or negative r values mean positive or negative correlations, respectively 
[49]. 
 
Results 
A HFD alters hippocampal IRS1 and IRS2 mRNA expression. ABA treatment can prevent these 
changes. 
We found that TNFα levels were increased significantly by HFD treatment, and ABA administration, 
along with a HFD, prevented this significant increase (F3,39 = 9.363). Similarly, we observed that the 
BDNF mRNA level in the hippocampus was significantly reduced in HFD-treated animals compared to 
SD and that the treatment with ABA in the drinking water prevented this reduction (F3,16 = 5.898). 
Interestingly, the APP mRNA expression levels also showed a significant increase with HFD exposure 
(F3,19 = 4.524).  
Next, we wanted to evaluate the effects of a HFD on the proteins’ expression of the insulin-signalling 
pathway. Even though it is widely accepted that a HFD and neuroinflammation induces insulin resistance, 
whether a HFD affects mRNA levels of IR, IRS1 and IRS2 is largely unknown. In our model, we 
observed a significant reduction of IRS2 mRNA levels in the hippocampus of rats fed a HFD with respect 
to SD (Table 2). Most interestingly, ABA treatment prevented this significant reduction in the 
hippocampal IRS2 levels in rats fed a HFD (F3,37 = 5.911). Moreover, there was a significant increase in 
the mRNA levels of IRS1 in those animals fed a HFD, which can also be rescued by ABA administration 
(F3,22 = 4.301) (Table 2). Hence, these results suggest that the modulation of IRS1 and IRS2 gene 
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expression may be different, depending on the environmental conditions, which suggests that these 
proteins may be involved in different cellular needs, in insulin signalling and in neuroinflammation. IR 
did not change with diet or ABA treatment; however, the IGF1R did show a change in those control 
samples that were treated with ABA (F3,16 = 3.025) (Table 2). 
ABA can effectively restore HFD-induced reduction in hippocampal IRS2 protein. 
To evaluate the effect of a HFD on protein expression in the hippocampus, we measured the levels of 
both IRS1 and IRS2 and the inflammatory markers phosphrorylated IKK (pIKK) [50] and Tau (pTau) 
[51] using a western blot (Fig. 1A). We observed that IRS2 protein levels were significantly lower in the 
HFD group (0.61 ± 0.05; n = 11) compared to SD group (0.99 ± 0.02; n = 9), HFD supplemented with 
ABA group (1.00 ± 0.16; n = 12) and the SD-ABA group (1.29 ± 0.17; n = 7), ANOVA (F3,35 = 4.897; p 
= 0.006) (Fig, 1B). In contrast, hippocampal IRS1 protein levels from matched samples were not different 
from each other [HFD (0.97 ± 0.12; n = 5), HFD-ABA (1.05 ± 0.12; n = 5), SD (0.96 ± 0.02; n = 5), SD-
ABA (1.31 ± 0.25; n = 5)] (Fig. 1C). On the other hand, pIKK did not show any significant differences 
between groups [HFD (1.38 ± 0.32; n = 6), HFD-ABA (1.28 ± 0.20, n = 6), SD (0.98 ± 0.01, n = 7), SD-
ABA (1.15 ± 0.07, n = 7)] (Fig. 1D). We found that ABA increased pTau expression in SD-ABA animals 
(1.37 ± 0.19; n = 7) with respect to the SD group (0.99 ± 0.02; n = 9), that the HFD-treated animals had 
lower levels, although not significantly lower (0.68 ± 0.12, n = 11), and ABA added to HFD group (0.88 
± 0.07; n = 11) did not significantly alter the pTau levels, ANOVA (F3,34 = 6.012; p = 0.002) (Fig. 1E). 
ABA rescues the HFD- induced reduction in hippocampal neurogenesis. 
To evaluate hippocampal neurogenesis, we quantified DCX, which was expressed in differentiating and 
migrating neurons during embryonic and postnatal development [52] using immunohistochemistry in the 
rostral (Bregma ˗3.72 mm) and caudal hippocampus (Bregma ˗6.00 mm) (Fig 2A), following the rat brain 
atlas [45]. Data were expressed as the mean of DCX positive neurons ± SEM. In the rostral hippocampus, 
we found that the number of DCX positive neurons decreased significantly in HFD-fed rats (131.9 ± 41.4; 
n = 6) compared to SD-fed controls (275 ± 34.15; n = 6). The ABA treatment rescued the DCX 
expression in HFD-ABA animals (339.1 ± 43.99; n = 6) and did not alter the DCX in SD animals (257.2 
± 34.15; n = 6). ANOVA (F3,20 = 6.150; p = 0.0039)] (Fig 2B). There were representative images of DCX 
positive neurons in SD (Fig. 2C), a HFD (Fig. 2D), SD+ABA, (Fig 2E) and HFD+ABA (Fig. 2F). An 
identical pattern was followed in the caudal hippocampus (data not shown). 
IRS1 and IR21 mRNA levels correlate differently with TNFα, BDNF and APP. 
We have observed that diet and ABA treatment can differently affect the expression of IRS1 and IRS2. 
To further understand the relationships of IRS expression and other biomarkers of inflammation, we 
aimed to ascertain if there was a relationship between the levels of IRS1 and IRS2 gene expression with 
TNFα, APP and BDNF. We observed that IRS1 correlates positively with TNFα (Pearson r = 0.574; p = 
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0.02) (Fig 3A), whereas IRS2 correlates negatively with TNFα (Pearson r = ˗0.498; p = 0.05) (Fig 3B). 
Interestingly, IRS1 showed a positive correlation with APP (Pearson r = 0.672; p = 0.003) (Fig 3C). In 
contrast, IRS2 did not correlate with APP either way (Fig 3D). None of the substrates showed any 
correlation with BDNF levels (Fig 3E and F, respectively). 
The IRS1 expression correlates with weight gain but IRS2 does not. 
Due to the different patterns of expression showed by both isoforms of IRS, we aimed to elucidate if there 
was a relationship between the percentage of weight gain and the IRS expression. Interestingly, IRS1 
showed a positive correlation with the percentage of weight gain (Pearson r = 0.498; p = 0.019) (Fig 4A). 
However, the IRS2 expression did not show any significant correlation when plotted versus the 
percentage of weight gain (Fig 4B).  
 
Discussion. 
Excessive caloric intake can induce neuroinflammation and insulin resistance. Both processes are 
considered major risk factors that lead to cognitive alterations [53–55].  
In this study, we have made use of a well-established model of neuroinflammation – feeding rats a HFD 
for three months – to study its effects on the insulin-signalling pathway. In addition, we have evaluated 
the effects of the phytohormone ABA in hippocampal insulin signalling. ABA targets peroxisome 
proliferator-activated receptor gamma (PPAR-γ) in a manner similar to the Thiazolidinediones class of 
anti-diabetic drugs [56, 57] and curcumin, a well-known potent anti-inflammatory molecule [58] and also 
PPAR-γ agonist [59]. In fact, given their capability to reduce inflammation, this family of PPAR-γ agonist 
molecules has been proposed as a new class of molecules with which to treat central nervous system 
disorders [60]. 
We have analysed the mRNA of IR and IGF1R and their substrates, IRS1 and IRS2. We found no 
changes in hippocampal IR or IGF1R in the hippocampus of HFD-fed animals compared to the controls. 
However, our study shows for the first time that a HFD can reduce IRS2 expression in hippocampal 
tissue, both at the messenger RNA and protein levels, therefore providing an additional plausible 
mechanism of hippocampal insulin resistance in obesity and metabolic syndrome. These results are also 
in line with previous reports showing that IRS2 is reduced in dorsal root ganglia from diabetic (insulin 
resistance) rodent models [61]. Moreover, in the gastrocnemius muscle, IRS2 expression was found to be 
significantly reduced in diabetic animals compared to the controls [62]. On the contrary, we observed that 
HFD increased IRS1 levels. These results may be paradoxical; however, they are in line with earlier 
reports indicating that IRS1 mRNA is increased in the hippocampus of APP/PS1 transgenic mice 
compared to aged-matched controls [63]. 
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Interestingly, we have observed that treatment with ABA restored IRS1 and IRS2 expression, which 
could account for beneficial effects improving the cognitive performance of HFD-fed animals [40]. These 
results are supported by studies showing that PPAR-γ agonists can restore pathological IRS levels, that 
curcumin reduced the IRS1 levels in double APP/PS1 transgenic mice [63] and that pioglitazone 
increased the pancreatic IRS2 expression in a model of diabetic transgenic mice [64].  
To our knowledge, our study reports for the first time that HFD alters hippocampal IRS1 and IRS2 
expression and that supplementation with ABA is capable of restoring these alterations. 
Protein expression was studied using immunodetection and confirmed the alterations observed in the 
IRS2 mRNA levels, but not IRS1 mRNA. This discrepancy in messenger and protein expression could be 
due to the fact that the IRS1 protein levels may be regulated by degradation, and, therefore, the increase 
in mRNA is not being detected in the protein. Paradoxically, pIKK and pTau were not found to be 
increased in a HFD as expected given the fact that inflammation augments the phosphorylation of IKK 
[65, 66] and that insulin resistance results in tau hyperphosphotylation [67]. Nevertheless, supporting our 
results, pIKK levels are not altered in HFD-treated rats [68], indicating that pIKK may not be a universal 
and reliable marker for neuroinflammation. However, further studies should be carried out to elucidate the 
role of pIKK in hippocampal HFD-induced inflammation. Similarly, future research will help to 
understand the conditions required for accumulation of pTau derived from an insulin-resistance situation. 
It is plausible that time is an important factor for observing such accumulation. 
Furthermore, we have observed that ABA treatment is capable of restoring a HFD-induced reduction in 
neurogenesis, as evaluated by DCX positive neurons in the subgranular layer of the dentate gyrus. It is 
well accepted that a HFD reduces neurogenesis and that exercise and learning can improve it [69]. 
Consistent with our data, many insulin sensitizer molecules used against type 2 diabetes have been proven 
effective in restoring altered neurogenesis [70]. In addition, BDNF signalling is closely related to 
neurogenesis modulation, synaptic plasticity and the formation and recall of hippocampal-dependent 
memories [71]. BDNF reduction has also been proposed as one of the earliest events in HFD-induced 
cognitive impairment [72, 73]. In this study, in addition to showing impaired neurogenesis, we observed 
that the BDNF mRNA levels were reduced in the hippocampus with HFD and that ABA treatment could 
efficiently prevent this reduction. This is in line with previous studies reporting that neurogenesis and 
BDNF levels can be rescued using insulin and BDNF-sensitizing nutritional compounds [74] and anti-
inflammatory supplementation [75]. BDNF may be able to induce IRS1 and IRS2 tyrosine 
phosphorylation [76] but, to date, it has not been reported to regulate IRS1 or IRS2 expression. In fact, we 
found no correlation between IRS1 and IRS2 with BDNF levels. 
On the other hand, TNFα, a well-accepted marker of neuroinflammation, insulin resistance and cognitive 
impairment [77], increases in the brain of HFD-treated animals [78]. As expected, we found that TNFα 
10 
 
levels were increased in the hippocampus of HFD-treated rats and that ABA treatment significantly could 
prevent it. This result confirms that ABA is an effective anti-neuroinflammatory molecule. Furthermore, 
since TNFα levels are also closely linked to impaired neurogenesis and reduction in BDNF [79], our 
study confirms the close relationship of these processes with IRS expression. 
APP transgenic mice have been extensively used as a model for Alzheimer’s disease in an attempt to 
over-express a mutated protein that promotes oligomers aggregation [80]. We have found that 
endogenous APP levels are increased in the hippocampus of HFD-fed rats. It is plausible that this 
increment can favour Aβ accumulation [81] and mediate some of the deleterious effects of a HFD in 
cognition. We found that ABA treatment could effectively counteract these effects, preventing the 
overexpression of APP. Other studies have also shown that supplementary nutrients can effectively 
downregulate APP endogenous expression [82]. Therefore, the anti-inflammatory and insulin-sensitizing 
actions also regulate APP expression, preventing further complications of Aβ deposition. 
Finally, to understand the relationship between IRSs, the biomarkers used in this study and obesity, we 
analysed the normalized levels of IRS1 and IRS2 with TNFα, APP, BDNF rat hippocampal tissue and the 
percentage of weight gain. Interestingly, we observed the levels of TNFα correlate inversely with the 
expression of IRS2 and positively with IRS1. This fact strongly suggests that IRS1 and IRS2 can be 
differentially affected by neuroinflammatory processes and therefore modulates distinct aspects of insulin 
resistance. Further confirming this hypothesis, we found that APP correlates positively with IRS1 but 
does not correlate at all with IRS2; thus, it is plausible that the signalling pathway that affects APP can 
target only IRS1 but not IRS2. Moreover, the percentage of weight gain correlates positively with IRS1 
but not with IRS2 expression.  
Considering all these data, we conclude that both IRS1 and IRS2 expression regulation, although 
modulating insulin and IGF1 signalling, are totally independent of each other, suggesting that their 
implication in neuroinflammation and brain insulin resistance may also be different. Further studies 
should be carried out to establish the mechanism underlying these differences, such as location, protein 
interactions and promoter sensitivity. These findings will be crucial for opening different methods of 
brain insulin resistance treatment. 
Moreover, we confirm that ABA can effectively restore neuroinflammation and neurogenesis, supporting 
the beneficial effects on memory that we have reported previously [40]. In addition, we show that ABA 
can also influence IRS1 and IRS2 expression levels, providing a mechanistic link to how ABA can restore 
insulin signalling.  
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Figure legends 
Table 1. Primers sequences 
Primer sequences were obtained from the Primer3 software tool. 
Table 2. Hippocampal mRNA expression of neuroinflammation markers and insulin/IGF-1 
pathway genes. 
The mRNa levels were quantified and RNA loading corrected using GAPDH as a housekeeping gene. 
Data are expressed as being normalized to SD levels. Data passed the KS normality test and were 
analysed using a one-way ANOVA followed by a post-hoc Newman-Keuls test. *p < 0.05, **p < 0.01 
*** p < 0.001, compared to HFD. 
Figure 1. A western blot analysis was carried out to evaluate the expression of the proteins in the 
hippocampus.  
Representative images of IRS2, IRS1, pIKK pTAU and loading control β-Actin (A). Quantifications of 
IRS2 protein levels (B); IRS1 (C); pIKK (D), pTAU (E). HFD (white columns); HFD-ABA (diagonal 
lines); SD (horizontal lines) and SD-ABA (black columns). Data are represented as the mean ± SEM 
(n = 6). The ANOVA was followed by a post-hoc Newman-Keuls Test (n = 5-11). *p < 0.05; 
**p < 0.01;*vs. HFD; #vs. HFD-ABA; +vs. SD.  
18 
 
Figure 2. ABA rescues the HFD-induced reduction in the number of DCX positive neurons in the 
hippocampus.  
A Patxinos drawing of a rostral hippocampus (Bregma ˗3,72 mm) (A). The quantification of DCX 
positive neurons (B). Data are represented as the mean ± SEM (n = 6) and analysed using a one-way 
ANOVA followed by  post-hoc Newman-Keuls test. *p < 0.05; **p < 0.01, with respect to HFD. The 
representative images are of DCX imunolabeling in SD (C); HFD (D); SD +ABA (E) and HFD+ABA (F). 
Calibration bar, 100 µm.  
Figure 3. The correlation of IRS1 and IRS2 with TNFα, APP and BDNF. The IRS1 expression 
correlates positively with the TNFα (A) and APP (B) expression. IRS1 does not correlate with the BDNF 
expression (C). The IRS2 gene expression correlates negatively with TNFα and does not correlate with 
the APP (E) or BDNF (F) expression.  
Figure 4. The correlation of IRS1 and IRS2 versus the percentage of weight gain. The IRS1 
expression correlates positively with the percentage of weight gain (A). There is no significant correlation 
between IRS2 and the percentage of weight gain (B).  
  
